Effect of interventional treatment alone or combined with Entecavir in patients with hepatocellular carcinoma
Latest Information Update: 25 May 2012
At a glance
- Drugs Entecavir (Primary)
- Indications Hepatitis B; Liver cancer
- Focus Therapeutic Use
- 21 May 2012 Planned end date changed from 1 Dec 2013 to 1 Jan 2013 as reported by Chinese Clinical Trial Register.
- 14 Oct 2011 New trial record